Skip to main content
Clinical Trials/NCT03070873
NCT03070873CompletedNot Applicable

Anatomical and Functional Outcomes of Perigee and Apogee Mesh in Total Pelvic Floor Reconstruction Versus Gynecare Prolift

Nanjing Medical University0 sites258 target enrollmentStarted: January 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
258
Primary Endpoint
Pelvic Organ Prolapse Quantification

Study Overview

Brief Summary

The investigators designed a prospective study in this article to evaluate the efficacy, the life quality and the complications of two different meshes of type I (one is Perigee/Apogee, the other is named Gynecare prolift) versus traditional surgery, and also studied the influence of some surgical procedures on the prognosis.

Detailed Description

Pelvic organ prolapse is defined as a downward descent of the pelvic organs that results in the protrusion of vagina, uterus, or both. The investigators designed a prospective study in this article to evaluate the efficacy, the life quality and the complications of two different meshes of type I (one is Perigee/Apogee, the other is named Gynecare prolift) versus traditional surgery. The investigators also studied the influence of some surgical procedures on the prognosis. In this study,The investigators divided the patients randomly into three groups :the group A was a total of 91 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction combined Perigee and Apogee polypropylene mesh(PA);the group B was a total of 97 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction with Gynecare prolift polypropylene mesh;the group C was a total of 70 patients who accepted transvaginal hysterectomy and anterior and posterior vaginal wall repair without any mesh.The investigators did POP-Q measurements and questionnaire preoperatively and postoperatively and recorded volume of bleeding,day of postoperative indwelling catheter and the mesh complications。

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Device Feasibility
Masking
Double (Participant, Investigator)

Masking Description

In the study the operation was performed by three surgeons, the patients received surgery by the doctor when the patients saw in the outpatient clinic.

Eligibility Criteria

Ages
50 Years to 85 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with stage III ~ IV degree of anterior and posterior vaginal wall prolapse and uterine prolapse (total pelvic floor prolapse) by the Pelvic Organ Prolapse Quantification System (POP-Q) were included

Exclusion Criteria

  • Simple anterior or posterior wall prolapse, simple uterine prolapse, combined with stress urinary incontinence, overactive bladder (OAB), pelvic floor repair surgery history and recurrent patients
  • Local or systemic conditions that would preclude surgery or affect healing such as restricted leg motion (inability to conform to the lithotomy position)
  • Vaginal bleeding;coagulation disorders
  • Infection,or uncontrolled hypertension and diabetes mellitus
  • Pelvic cancer and radiation to the pelvic area in the previous 6 months.
  • Also women of reproductive age, and planning of pregnancy were also excluded for mesh usage.

Outcomes

Primary Outcomes

Pelvic Organ Prolapse Quantification

Time Frame: at 24 months after surgery

the prolapse of stage II and above is defined as recurrence in POP-Q stage.

mesh exposure

Time Frame: at 24 months after surgery

mesh was seen in the vagina by gynecological examination

sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire

Time Frame: baseline

PISQ-12

pelvic floor distress inventory short form

Time Frame: baseline

PFDI-20

Secondary Outcomes

  • Number of constipation(1 months after surgery)
  • Volume of bleeding(during the operation)
  • Day of postoperative indwelling catheter(1 months after surgery)
  • Elevated blood pressure(during the operation)
  • stress urinary incontinence(3 months after surgery)

Investigators

Sponsor
Nanjing Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xirong Guo

Vice president of Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University

Nanjing Medical University

Similar Trials